AbstractFor the purpose of post-marketing drug safety surveillance, which has traditionally relied on the voluntary reporting of individual cases of adverse drug events (ADEs), other sources of information are now being explored, including electronic health records (EHRs), which give us access to enormous amounts of longitudinal observations of the treatment of patients and their drug use. Adverse drug events, which can be encoded in EHRs with certain diagnosis codes, are, however, heavily underreported. It is therefore important to develop capabilities to process, by means of computational methods, the more unstructured EHR data in the form of clinical notes, where clinicians may describe and reason around suspected ADEs. In this study, we...
148 p.This work focuses on the automatic extraction of Adverse Drug Reactions (ADRs) in Electronic H...
International audienceThe detection of Adverse Drug Reactions (ADRs) in clinical records plays a piv...
AbstractA significant amount of information about drug-related safety issues such as adverse effects...
AbstractFor the purpose of post-marketing drug safety surveillance, which has traditionally relied o...
Electronic health records have emerged as a promising source of information for pharmacovigilance. A...
BACKGROUND: Pharmacovigilance and drug-safety surveillance are crucial for monitoring adverse drug e...
Adverse drug events (ADEs) are unintended responses to medical treatment. They can greatly affect a ...
International audienceBackground: Patient data, such as electronic health records or adverse event r...
International audienceBackground: Patient data, such as electronic health records or adverse event r...
International audiencePatient Electronic Health Records (EHRs) constitute an essential resource for ...
Adverse drug events (ADEs) are unintended responses to medical treatment. They can greatly affect a ...
INTRODUCTION: This work describes the Medication and Adverse Drug Events from Electronic Health Reco...
The collection of narrative spontaneous reports is an irreplaceable source for the prompt detection ...
Electronic Health Records (EHR) narratives are a rich source of information, embedding high-resoluti...
AbstractPharmacovigilance involves continually monitoring drug safety after drugs are put to market....
148 p.This work focuses on the automatic extraction of Adverse Drug Reactions (ADRs) in Electronic H...
International audienceThe detection of Adverse Drug Reactions (ADRs) in clinical records plays a piv...
AbstractA significant amount of information about drug-related safety issues such as adverse effects...
AbstractFor the purpose of post-marketing drug safety surveillance, which has traditionally relied o...
Electronic health records have emerged as a promising source of information for pharmacovigilance. A...
BACKGROUND: Pharmacovigilance and drug-safety surveillance are crucial for monitoring adverse drug e...
Adverse drug events (ADEs) are unintended responses to medical treatment. They can greatly affect a ...
International audienceBackground: Patient data, such as electronic health records or adverse event r...
International audienceBackground: Patient data, such as electronic health records or adverse event r...
International audiencePatient Electronic Health Records (EHRs) constitute an essential resource for ...
Adverse drug events (ADEs) are unintended responses to medical treatment. They can greatly affect a ...
INTRODUCTION: This work describes the Medication and Adverse Drug Events from Electronic Health Reco...
The collection of narrative spontaneous reports is an irreplaceable source for the prompt detection ...
Electronic Health Records (EHR) narratives are a rich source of information, embedding high-resoluti...
AbstractPharmacovigilance involves continually monitoring drug safety after drugs are put to market....
148 p.This work focuses on the automatic extraction of Adverse Drug Reactions (ADRs) in Electronic H...
International audienceThe detection of Adverse Drug Reactions (ADRs) in clinical records plays a piv...
AbstractA significant amount of information about drug-related safety issues such as adverse effects...